The combined data support the model that ROS-driven FOXO3 activation enhances the cytotoxic effect of MG-2477 by modulating the regulation of NOXA, Survivin and possibly other death regulators, which triggers additional death pathways and eventually drives the tumor cell into cell death. The gene discussed is FOXO3; the disease is neoplasm.